{"doi":"10.17615/4har-0348","title":"Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia","abstract":"Fostamatinib, a spleen tyrosine kinase inhibitor, has been reported to improve outcomes of COVID-19. To evaluate the efficacy and safety of fostamatinib in adults hospitalized with COVID-19 and hypoxemia. This multicenter, phase 3, placebo-controlled, double-blinded randomized clinical trial was conducted at 41 US sites and 21 international sites between November 17, 2021, and September 27, 2023; the last follow-up visit was December 31, 2023. Participants were adults aged 18 years or older hospitalized with acute SARS-CoV-2 infection and hypoxemia. Data were analyzed between January 10 and March 8, 2024. Fostamatinib, 150 mg orally twice daily for 14 days, or placebo. The primary outcome was oxygen-free days, an ordinal outcome classifying a participant’s status at day 28 based on mortality and duration of supplemental oxygen use. An adjusted odds ratio (AOR) greater than 1.0 was considered to indicate superiority of fostamatinib over placebo. A key secondary outcome was 28-day all-cause mortality. Safety outcomes included elevated transaminase values, neutropenia, and hypertension. Of the 400 participants randomized (median age, 67 years [IQR, 58-76 years]; 210 [52.5%] men), 199 received fostamatinib and 201 received placebo. The mean (SD) number of oxygen-free days was 13.4 (12.4) in the fostamatinib group and 14.2 (12.1) in the placebo group (unadjusted mean difference, −1.26 days [95% CI, −3.52 to 1.00 days]; AOR, 0.82 [95% credible interval (CrI), 0.58-1.17]). Mortality at 28 days occurred in 22 of 195 patients (11.3%) in the fostamatinib group and 16 of 197 (8.1%) in the placebo group (AOR, 1.44; 95% CrI, 0.72-2.90). Aspartate aminotransferase elevation occurred more commonly in the fostamatinib group (23 [11.6%]) than in the placebo group (11 [5.5%]; AOR, 2.28; 95% CrI, 1.07-4.84). Other safety outcomes were similar between groups. In this randomized clinical trial of adults hospitalized with COVID-19 and hypoxemia, fostamatinib did not increase the number of oxygen-free days compared with placebo. These results do not support the hypothesis that fostamatinib improves outcomes among adults hospitalized with hypoxemia during the Omicron era. ClinicalTrials.gov Identifier: NCT04924660","journal":"UNC Libraries","year":2024,"id":507077,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9585,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":237085,"name":"Jeffrey R. Strich","orcid":"0000-0002-5671-1130","position":1,"is_corresponding":false},{"id":104966,"name":"Nicole M. Iovine","orcid":"0000-0002-5032-6485","position":2,"is_corresponding":false},{"id":84465,"name":"Peter Chen","orcid":"0000-0002-5330-1718","position":3,"is_corresponding":false},{"id":786793,"name":"Nina Gentile","orcid":"0000-0002-1222-5966","position":4,"is_corresponding":false},{"id":105998,"name":"David N. Hager","orcid":"0000-0002-5148-4872","position":5,"is_corresponding":false},{"id":105982,"name":"Nathan I. Shapiro","orcid":"0000-0003-3508-4390","position":6,"is_corresponding":false},{"id":105993,"name":"Akram Khan","orcid":"0000-0003-3091-632X","position":7,"is_corresponding":false},{"id":656638,"name":"Matthew S. Shotwell","orcid":"0000-0002-1480-0637","position":8,"is_corresponding":false},{"id":105999,"name":"Adit A. Ginde","orcid":"0000-0003-2325-206X","position":9,"is_corresponding":false},{"id":105734,"name":"Estelle S. Harris","orcid":null,"position":10,"is_corresponding":false},{"id":106002,"name":"Wesley H. Self","orcid":"0000-0002-9300-3045","position":11,"is_corresponding":false},{"id":1028133,"name":"Kelly Walsh","orcid":"0000-0001-5266-0658","position":12,"is_corresponding":false},{"id":928526,"name":"Josh DeClercq","orcid":"0000-0002-8171-5766","position":13,"is_corresponding":false},{"id":888642,"name":"Harry Schrager","orcid":null,"position":14,"is_corresponding":false},{"id":684481,"name":"Vicente Estrada","orcid":"0000-0002-7795-5986","position":15,"is_corresponding":false},{"id":400480,"name":"Félix Gutiérrez","orcid":"0000-0002-9485-6867","position":16,"is_corresponding":false},{"id":544282,"name":"Basmah Safdar","orcid":"0000-0002-9640-7133","position":17,"is_corresponding":false},{"id":386202,"name":"Subhashini A. Sellers","orcid":"0000-0003-2852-4634","position":18,"is_corresponding":false},{"id":889462,"name":"Andrew Goodwin","orcid":"0000-0002-6543-9458","position":19,"is_corresponding":false},{"id":105997,"name":"Todd W. Rice","orcid":"0000-0002-7136-5408","position":20,"is_corresponding":false},{"id":895206,"name":"Li Wang","orcid":"0000-0001-9580-2476","position":21,"is_corresponding":false},{"id":888646,"name":"Marjolein de Wit","orcid":null,"position":22,"is_corresponding":false},{"id":242316,"name":"Jonathan D. Casey","orcid":"0000-0002-0977-290X","position":23,"is_corresponding":false},{"id":846570,"name":"Michelle Harkins","orcid":"0000-0002-9679-2553","position":24,"is_corresponding":false},{"id":437047,"name":"Lisa H. Merck","orcid":null,"position":25,"is_corresponding":false},{"id":1028863,"name":"Krystle D. Apodaca","orcid":null,"position":26,"is_corresponding":false},{"id":105984,"name":"Kevin W. Gibbs","orcid":"0000-0002-5272-2289","position":27,"is_corresponding":false},{"id":45558,"name":"Ivor S. Douglas","orcid":"0000-0002-4541-1431","position":28,"is_corresponding":false},{"id":237082,"name":"Joseph E. Levitt","orcid":"0000-0001-5316-4971","position":29,"is_corresponding":false},{"id":862857,"name":"Joaquín Burgos","orcid":"0000-0001-8445-3047","position":30,"is_corresponding":false},{"id":105983,"name":"D. Clark Files","orcid":"0000-0002-1595-4080","position":31,"is_corresponding":false},{"id":311303,"name":"Kristin Hudock","orcid":"0000-0001-5429-3687","position":32,"is_corresponding":false},{"id":105988,"name":"Michelle N. Gong","orcid":"0000-0001-7952-5384","position":33,"is_corresponding":false},{"id":407382,"name":"Jonathan S. Schildcrout","orcid":"0000-0003-2276-2551","position":34,"is_corresponding":false},{"id":15360,"name":"Gordon R. Bernard","orcid":"0000-0002-4721-3068","position":35,"is_corresponding":false},{"id":888649,"name":"Amanda J. Bistran-Hall","orcid":null,"position":36,"is_corresponding":false},{"id":382584,"name":"Michael J. Lanspa","orcid":"0000-0003-0968-4755","position":37,"is_corresponding":false},{"id":89099,"name":"Michael R. Filbin","orcid":"0000-0002-2588-7504","position":38,"is_corresponding":false},{"id":264405,"name":"Matthew W. Semler","orcid":"0000-0002-7664-8263","position":39,"is_corresponding":false},{"id":511535,"name":"Meghan M. Joly","orcid":"0009-0003-3329-3321","position":40,"is_corresponding":false},{"id":1254633,"name":"Ari Moskowitz","orcid":"0009-0003-5223-3121","position":41,"is_corresponding":false},{"id":487344,"name":"Tom Boyles","orcid":"0000-0002-5676-8081","position":42,"is_corresponding":false},{"id":1255071,"name":"José Ramón Paño‐Pardo","orcid":null,"position":43,"is_corresponding":false},{"id":59341,"name":"Jeffrey M. Sturek","orcid":"0000-0002-2731-3299","position":44,"is_corresponding":false},{"id":927853,"name":"Aaron Barksdale","orcid":"0000-0002-7687-1203","position":45,"is_corresponding":false},{"id":263663,"name":"Ali Javaheri","orcid":"0000-0001-6657-331X","position":46,"is_corresponding":false},{"id":628059,"name":"Brian Tiffany","orcid":"0000-0002-6894-7933","position":47,"is_corresponding":false},{"id":326203,"name":"Abhijit Duggal","orcid":"0000-0003-4220-2359","position":48,"is_corresponding":false},{"id":1255070,"name":"Neeraj Desai","orcid":null,"position":49,"is_corresponding":false},{"id":1255072,"name":"Nazreen Hussen","orcid":null,"position":50,"is_corresponding":false},{"id":870190,"name":"Mark Tidswell","orcid":"0000-0001-6333-6810","position":51,"is_corresponding":false},{"id":432430,"name":"Jill M. Pulley","orcid":"0000-0003-0316-5540","position":52,"is_corresponding":false},{"id":228989,"name":"Yves Rosenberg","orcid":"0000-0002-4131-1927","position":53,"is_corresponding":false},{"id":360928,"name":"James Troendle","orcid":"0000-0002-7903-1015","position":54,"is_corresponding":false},{"id":16593,"name":"Sean P. Collins","orcid":"0000-0002-2305-9836","position":0,"is_corresponding":true}],"reference_count":0,"raw_metadata":null,"created_at":"2026-07-19T02:10:58.484528Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}